Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added, replacing Revision: v3.5.2. This indicates a new version of the page was deployed.
    Difference
    0.0%
    Check dated 2026-04-30T15:36:55.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T10:43:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The study page now displays 'Results Submitted' where it previously showed 'No Results Posted', indicating that results are available or under review for this record.
    Difference
    0.0%
    Check dated 2026-04-09T08:25:50.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. No study data, eligibility criteria, or on-page guidance were changed.
    Difference
    0.0%
    Check dated 2026-03-18T18:04:52.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:57:30.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the government funding status notice about a lapse in funding was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T09:18:05.000Z thumbnail image

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.